Skip to main content
Premium Trial:

Request an Annual Quote

Tm Said Undisclosed Dx Shop Will Sell Its RVP Panel in Turkey; Will File for CE Mark This Year

NEW YORK, April 19 (GenomeWeb News) - Tm Bioscience has signed on a "major diagnostics distributor" to sell its ID-Tag respiratory viral panel in Turkey, Tm said today.

 

Tm calls the deal "the first of a number of regional distribution agreements that we anticipate signing" for the product, which the company said may play in the emerging avian flu space.

 

According to the World Health Organization, H5N1-strain bird flu has killed at least 110 people worldwide since late 2003, including individuals in Vietnam, Indonesia, Thailand, China, Cambodia, Azerbaijan, Turkey, Iraqand Egypt. "Our test will be marketed in one of the areas hardest hit so far, where we anticipate it will be used as a first line surveillance tool for suspected avian flu infections," Tm President and CEO Greg Hines said in a statement.

 

Tm said it "anticipates" it will launch the ID-Tag RVP test in Turkeyin the "coming weeks." The company also said it "expects to obtain CE marking for this product in 2006."

 

The ID-Tag RVP test is designed to detect various strains of viruses and subtypes, including H5.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.